Citation Impact
Citing Papers
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
2014 Standout
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
2009
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
2007
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
2003
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
2015
Docetaxel Nanotechnology in Anticancer Therapy
2012
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
1999
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
FGFR3 mutations in prostate cancer: association with low-grade tumors
2009
PARP inhibitor combination therapy
2016
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
The Acute Respiratory Distress Syndrome
2000 Standout
YAP/TAZ at the Roots of Cancer
2016
The metabolic syndrome
2010 Standout
A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
2009
A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans
2009
SET8 promotes epithelial–mesenchymal transition and confers TWIST dual transcriptional activities
2011
Cancer drug resistance: an evolving paradigm
2013 Standout
Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2
2007
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
2007
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid
2001
Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen Receptor
2007
Extracting Dynamics from Static Cancer Expression Data
2008
Nasopharyngeal carcinoma
2019 Standout
Naturally occurring B-cell responses to breast cancer
2003
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
2014 Standout
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
2008
Imaging angiogenesis of genitourinary tumors
2010
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Epithelial Cell Plasticity in Development and Tumor Progression
1999
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
2010
YAP/TAZ as therapeutic targets in cancer
2016
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
2006 StandoutNobel
Stromal myofibroblasts are drivers of invasive cancer growth
2008
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
2010 StandoutNature
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
2013
Application potential of toll-like receptors in cancer immunotherapy
2016
Pancreatic Adenocarcinoma
2014 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Developmental regulation of the growth plate
2003 StandoutNature
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
FGF Signaling in Prostate Tumorigenesis—New Insights into Epithelial-Stromal Interactions
2007
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
EMT, the cytoskeleton, and cancer cell invasion
2009
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
2006
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements
2004
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
2006
The emerging roles of YAP and TAZ in cancer
2015
DNA repair dysregulation from cancer driver to therapeutic target
2012
Fibroblast growth factor receptor signaling through MEK–ERK is required for prostate bud induction
2007
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Fibroblast Growth Factor Receptors as Molecular Targets in Thyroid Carcinoma
2004
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
2012
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
What We Talk About When We Talk About Fat
2014 Standout
Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas
2013
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer
2008
Fibroblasts in cancer
2006 Standout
Fibroblast Growth Factor Signaling in Metabolic Regulation
2016
The role of fibroblast growth factors and their receptors in prostate cancer
2004
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties
2020
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes
2001
MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
2012
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.
2003
TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition
2011
Nonviral Vectors for Gene Delivery
2008 Standout
Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
1999
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
2002
Hippo Pathway Regulation of Gastrointestinal Tissues
2014
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
2017
Mechanisms of Motility in Metastasizing Cells
2010
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
2011
FGFR4 Arg388 Allele Is Associated With Resistance to Adjuvant Therapy in Primary Breast Cancer
2006
Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function
1999
Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
2012
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
2018
Cancer Genome Landscapes
2013 StandoutScience
Up-regulation of the chondrogenicSox9gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway
2000
Distinct Roles of Fibroblast Growth Factor Receptor 1 and 2 in Regulating Cell Survival and Epithelial-Mesenchymal Transition
2007
Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis
2006
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
2015
The Metabolic Syndrome
2008 Standout
The Biology of YAP/TAZ: Hippo Signaling and Beyond
2014
The lncRNA Hand2os1/Uph locus orchestrates heart development through regulation of precise expression of Hand2
2019
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Genetics and biology of pancreatic ductal adenocarcinoma
2016
Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis
2001
Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer
2009
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
2005
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
2017
Works of Fen Wang being referenced
Zinc Finger DHHC-Type Containing 13 Regulates Fate Specification of Ectoderm and Mesoderm Cell Lineages by Modulating Smad6 Activity
2014
Toll-Like Receptors and Prostate Cancer
2014
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
2015
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia
2003
Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition
2007
Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis
2008
Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis
2009
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
2012
Direct Cell Cycle Regulation by the Fibroblast Growth Factor Receptor (FGFR) Kinase through Phosphorylation-dependent Release of Cks1 from FGFR Substrate 2
2004
Antineoplastic drugs that interfere with iron metabolism in cancer cells
1997
FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet–Induced Fatty Liver
2007
Two differentially expressed genes in normal human prostate tissue and in carcinoma.
1996
Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy.
2002
Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis
2007
A common Shox2-Nkx2-5 antagonistic mechanism primes the pacemaking cell fate in the pulmonary vein myocardium and sinoatrial node
2015
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis
2006
Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
2001
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
1997
Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.
2012
Comparison of MRI, CT and 18F-FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies.
2016
Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors
2004
Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
2003
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
2014
CANCER CELL CULTURE—METHODS AND PROTOCOLS
2003
Role of epithelial cell fibroblast growth factor receptor substrate 2α in prostate development, regeneration and tumorigenesis
2008